Civic Data
FDA RecallsUSDA RecallsAbout

FDA Recalls

  • Food recalls
  • Drug recalls
  • Device recalls

USDA Recalls

  • All USDA recalls
  • Poultry recalls
  • Meat recalls
  • Egg recalls

About

  • About us
  • FDA guides
  • USDA guides
  • Data sources
  • Privacy policy

Data

  • OpenFDA API
  • USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

  1. FDA Recalls
  2. ›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification
AllClass IClass IIClass III
Status
AllOngoingCompletedTerminated
Date
All timePast 30 daysPast 12 months

Showing 6401–6420 of 17,773 recalls

Class IITerminated

Testosterone Topical Cream 4%

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Finasteride/Biotin 1 mg/50 mcg

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class II
Terminated

Magic Bullet Supplement

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Sildenafil 200 mg Troche (Clinic)

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Progesterone 50 mg capsules

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Liothyronine (T3) 92.5 MCG

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

DHEA/Pregnenol One 10.25 MG Cap

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Tadalafil 20 mg Troche

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

T3/T4 SR 9 mcg/38 mcg capsule

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IITerminated

Liothyronine (T3) 80 mcg SR cap

MPRX, Inc. dba Medical Park Pharmacy

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

December 18, 2019 · DrugView details →
Class IIOngoing

Glenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-20

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Presence of NDMA impurity detected in product.

December 17, 2019 · DrugView details →
Class IIOngoing

Glenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-01

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Presence of NDMA impurity detected in product.

December 17, 2019 · DrugView details →
Class ITerminated

Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX

Motto International Corp

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

December 17, 2019 · DrugView details →
Class IIOngoing

Glenmark Ranitidine Tablets USP 150 mg Rx Only 60 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-248-60

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Presence of NDMA impurity detected in product.

December 17, 2019 · DrugView details →
Class IIOngoing

Glenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-248-05

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Presence of NDMA impurity detected in product.

December 17, 2019 · DrugView details →
Class IITerminated

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Hikma Pharmaceuticals USA Inc.

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

December 17, 2019 · DrugView details →
Class ITerminated

Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Motto International Corp

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

December 17, 2019 · DrugView details →
Class ITerminated

Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX

Motto International Corp

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

December 17, 2019 · DrugView details →
Class ITerminated

Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Motto International Corp

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

December 17, 2019 · DrugView details →
Class IIOngoing

Glenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-248-01

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Presence of NDMA impurity detected in product.

December 17, 2019 · DrugView details →
← PreviousPage 321 of 889Next →